A. Sandhofer

发表

Weight loss increases soluble leptin receptor levels and the soluble receptor bound fraction of leptin.

S. Kaser, M. Laimer, H. Weiss, 2002, Obesity research.

The novel insulin resistance parameters RBP4 and GLP-1 in patients treated with valproic acid: Just a sidestep?

G. Walser, G. Luef, A. Tschoner, 2013, Epilepsy Research.

Soluble leptin receptor and soluble receptor-bound fraction of leptin in the metabolic syndrome.

B. Paulweber, S. Kaser, M. Laimer, 2003, Obesity research.

Markers of chronic inflammation and obesity: a prospective study on the reversibility of this association in middle-aged women undergoing weight loss by surgical intervention

S. Kaser, M. Laimer, H. Weiss, 2002, International Journal of Obesity.

Lipoprotein profile and cholesteryl ester transfer protein in neonates.

S. Kaser, J. Patsch, U. Stanzl, 2001, Metabolism: clinical and experimental.

Effect of obesity and insulin sensitivity on adiponectin isoform distribution

A. Stadlmayr, B. Paulweber, S. Kaser, 2008, European journal of clinical investigation.

Relationship Between Cholesteryl Ester Transfer Protein and Atherogenic Lipoprotein Profile in Morbidly Obese Women

S. Kaser, M. Laimer, H. Weiss, 2002, Arteriosclerosis, thrombosis, and vascular biology.

Separating the Mechanism-Based and Off-Target Actions of Cholesteryl Ester Transfer Protein Inhibitors With CETP Gene Polymorphisms

Meena Kumari, Shah Ebrahim, Debbie A Lawlor, 2010, Circulation.

The Taq1B‐variant in the Cholesteryl Ester–Transfer Protein Gene and the Risk of Metabolic Syndrome

B. Paulweber, S. Kaser, M. Laimer, 2008, Obesity.

Are plasma VEGF and its soluble receptor sFlt-1 atherogenic risk factors? Cross-sectional data from the SAPHIR study.

B. Paulweber, B. Iglseder, R. Kirchmair, 2009, Atherosclerosis.

The influence of two variants in the adenosine triphosphate-binding cassette transporter 1 gene on plasma lipids and carotid atherosclerosis.

B. Paulweber, B. Iglseder, S. Kaser, 2008, Metabolism: clinical and experimental.

The MTP -493TT genotype is associated with peripheral arterial disease: results from the Linz Peripheral Arterial Disease (LIPAD) Study.

H. Ulmer, T. Mueller, M. Haltmayer, 2008, Clinical biochemistry.

Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro.

H. Tilg, A. Kaser, S. Kaser, 2003, Biochemical and biophysical research communications.

Effect of pronounced weight loss on visceral fat, liver steatosis and adiponectin isoforms

H. Tilg, S. Kaser, A. Tschoner, 2008, European journal of clinical investigation.

Non-alcoholic fatty liver disease (NAFLD), insulin resistance and lipid profile in antiepileptic drug treatment

E. Trinka, K. Seppi, G. Bauer, 2009, Epilepsy Research.

Phospholipid and cholesteryl ester transfer are increased in lipoprotein lipase deficiency

B. Paulweber, S. Kaser, J. Patsch, 2003, Journal of internal medicine.

Anti-thymocyte globulin treatment of a patient for paroxysmal nocturnal haemoglobinuria-aplastic anaemia syndrome: complement activation and transient decrease of the PNH clone.

D. Niederwieser, M. Dierich, C. Ebenbichler, 1997, Immunobiology.

Cholesteryl ester transfer protein gene expression is not specifically regulated by CCAAT/enhancer-binding protein in HepG2-cells.

J. Patsch, W. Doppler, A. Ritsch, 1999, Atherosclerosis.

Insulin sensitivity is impaired in heterozygous carriers of lipoprotein lipase deficiency

B. Paulweber, B. Iglseder, L. Malaimare, 2002, Diabetologia.

Scavenger receptor class B type I polymorphisms and peripheral arterial disease.

T. Mueller, M. Haltmayer, J. Patsch, 2007, Metabolism: clinical and experimental.

Influence of obesity and insulin sensitivity on phospholipid transfer protein activity

B. Paulweber, S. Kaser, B. Föger, 2001, Diabetologia.

Valvular disease and myocardial infarctions in a patient with Behçet disease.

A. Gschwendtner, C. Wiedermann, F. Weidinger, 2003, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

Two novel mutations in the lipoprotein lipase gene in a family with marked hypertriglyceridemia in heterozygous carriers. Potential interaction with the polymorphic marker D1S104 on chromosome 1q21-q23.

B. Paulweber, H. Wiebusch, J. Patsch, 2000, Journal of lipid research.

Two novel mutations in the lipoprotein lipase gene in a family with marked hypertriglyceridemia in heterozygous carriers : potential interaction with the polymorphic marker D 1 S 104 on chromosome 1 q 21 – q 23

B. Paulweber, H. Wiebusch, J. Patsch, 2000 .

Effect of bariatric surgery on both functional and structural measures of premature atherosclerosis.

S. Kaser, A. Tschoner, C. Ciardi, 2009, European heart journal.

Influence of leptin and insulin on lipid transfer proteins in human hepatoma cell line, HepG2

R. Kirchmair, S. Kaser, B. Föger, 2001, International Journal of Obesity.

Plasma cholesteryl ester transfer protein concentrations predict cardiovascular events in patients with coronary artery disease treated with pravastatin

J. Patsch, E. Kvas, P. Marschang, 2006, Journal of internal medicine.

Influence of Visceral Obesity and Liver Fat on Vascular Structure and Function in Obese Subjects

H. Tilg, S. Kaser, M. Laimer, 2009, Obesity.

Cholesteryl Ester Transfer Protein in Metabolic Syndrome

B. Paulweber, S. Kaser, M. Laimer, 2006, Obesity.

Body adiposity index and other indexes of body composition in the SAPHIR study: Association with cardiovascular risk factors

B. Paulweber, C. Lamina, S. Kaser, 2012, Obesity.

Cholesteryl ester transfer protein and hepatic lipase gene polymorphisms: effects on hepatic mRNA levels, plasma lipids and carotid atherosclerosis.

B. Paulweber, S. Soyal, B. Iglseder, 2011, Atherosclerosis.

Cholesteryl Ester Transfer Protein and Mortality in Patients Undergoing Coronary Angiography: The Ludwigshafen Risk and Cardiovascular Health Study

W. März, B. Boehm, H. Scharnagl, 2010, Circulation.

Flow-mediated, endothelium-dependent vasodilatation is impaired in male body builders taking anabolic-androgenic steroids.

B. Föger, B. Mangweth, W. Sturm, 2001, Atherosclerosis.

Antithrombin and near-fatal exertional heat stroke.

J. Patsch, C. Pechlaner, P. Schratzberger, 2002, Acta medica Austriaca.

Effect of pronounced weight loss on the nontraditional cardiovascular risk marker matrix metalloproteinase-9 in middle-aged morbidly obese women

S. Kaser, M. Laimer, H. Weiss, 2005, International Journal of Obesity.

Comparison of different definitions of the metabolic syndrome

B. Paulweber, B. Iglseder, C. Ebenbichler, 2007, European journal of clinical investigation.

Dyslipidemia and thrombosis: causal relationship or epiphenomenon of sedentary lifestyle?

W. Sturm, A. Sandhofer, 2005, Arteriosclerosis, thrombosis, and vascular biology.

Effects of weight loss on PLTP activity and HDL particle size

S. Kaser, M. Laimer, C. Ebenbichler, 2004, International Journal of Obesity.

Non-alcoholic fatty liver disease (NAFLD), insulin resistance and lipid profile in antiepileptic drug treatment

E. Trinka, K. Seppi, G. Bauer, 2009 .